Improvement in Clinical Features of L-NAME-Induced Preeclampsia-like Rats through Reduced SERPINA5 Expression
Biomolecules · 14.12.2023 · 13 (12) · 1792
DOI: 10.3390/biom13121792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 14.12.2023. Verfasst von Shanshui Zeng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China. Hauptthemen laut MEDLINE: Pre-Eclampsia, Hypertension. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: fund from Guangzhou Women and Children's Medical Center, National Natural Science Foundation of China, National Natural Science Fund of China.
Abstract (Originalsprache)
Pre-eclampsia (PE) is a severe pregnancy disorder that poses a significant health risk to both mother and fetus, with no preventive or therapeutic measures. Our previous research suggested an association between elevated SERPINA5 levels and PE features. This study investigated whether SERPINA5 could be a potential therapeutic target for PE. We established PE-like features in pregnant rats using L-NAME (75 mg/kg/d) treatment. Adenoviruses carrying overexpressed or suppressed SERPINA5 genes were intravenously injected into these PE rats on the fifth and seventh days of pregnancy. We evaluated the rats’ systolic blood pressure, urine protein concentration, and placental and fetal metrics and histology. Placental gene expression following SERPINA5 overexpression was evaluated using mRNA sequencing. The L-NAME-induced PE rat model observed a significant increase in placental and peripheral SERPINA5 levels. The overexpression of SERPINA5 exacerbated L-NAME-induced hypertension and proteinuria in pregnant rats. A histology examination revealed a smaller placental junctional zone in L-NAME + overexpressing rats. Placental gene expression analysis in the L-NAME + overexpressing group indicated increased coagulation activation. L-NAME-induced hypertension and proteinuria were mitigated when SERPINA5 expression was suppressed. Additionally, placental development was improved in the SERPINA5-suppressed group. Our findings suggested that SERPINA5 may worsen L-NAME-induced PE-like features by promoting the activation of the coagulation cascade. Therefore, reducing SERPINA5 expression could potentially serve as a therapeutic strategy for PE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China.
ORCID-Profile: Shanshui Zeng, Min Jiang, Hongling Yang, Yan Long
Förderung
- fund from Guangzhou Women and Children's Medical Center
- National Natural Science Foundation of China
- National Natural Science Fund of China
- Guangzhou Women and Children’s Medical Center
- Natural Science Fund of Guangdong
- Science and Technology Program of Guangzhou
Zitieren
APA
Zeng, S., Liu, Z., Yin, J., Li, S., Jiang, M., Yang, H., & Long, Y. (2023). Improvement in Clinical Features of L-NAME-Induced Preeclampsia-like Rats through Reduced SERPINA5 Expression. Biomolecules, 13(12), 1792. https://doi.org/10.3390/biom13121792
Vancouver
Zeng S, Liu Z, Yin J, Li S, Jiang M, Yang H, et al. Improvement in Clinical Features of L-NAME-Induced Preeclampsia-like Rats through Reduced SERPINA5 Expression. Biomolecules. 2023;13(12):1792. doi:10.3390/biom13121792
BibTeX
@article{Zeng2023,
author = {Zeng, Shanshui and Liu, Zimeng and Yin, Jiaye and Li, Shu and Jiang, Min and Yang, Hongling and Long, Yan},
title = {Improvement in Clinical Features of L-NAME-Induced Preeclampsia-like Rats through Reduced SERPINA5 Expression},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {12},
pages = {1792},
doi = {10.3390/biom13121792}
}
EUVIMED